ECMOLife: 2021 Global Frost&Sullivan Award for New Product Innovation in the ECMO industry
Eurosets is proud to announce that it’s novel Extracorporeal Life Support System, ECMOLife, has been recognized with the 2021 Global Frost&Sullivan Award for New Product Innovation in the global extracorporeal membrane oxygenation (ECMO) industry.
Each year Frost & Sullivan, a worldwide leader in consulting and growth accelerator, identifies companies that consistently develop new growth strategies based on a visionary understanding of the future and, thus, more effectively address new challenges and opportunities.
“Eurosets addresses market needs and existing gaps in clinical adoption by creating an advanced and new-generation product to improve the therapy’s clinical efficiency and outcome.”
Srinath Venkatasubramanian, Industry Analyst, Transformational Health
“Eurosets’s ECMOLife device, even though new in the market, has already gained fast adoption, with about 60 centers actively using the device on-site”
Srinath Venkatasubramanian, Industry Analyst, Transformational Health
Frost & Sullivan’s global team of growth pipeline experts continuously identifies and evaluates growth opportunities across multiple industries, technologies, and regions of the world.
This approach involves deep strategic deliberation around best practices and the development of core analytics across the entire value chain of specific products and services. As part of this ongoing effort, Frost & Sullivan recognizes Eurosets for its valuable achievements in the ECMO industry through ECMOLife disruptive technology.
ECMOLife recognition signifies an even greater accomplishment considering that Frost & Sullivan strictly reserves this recognition to companies at the innovation and growth forefront in their respective industries. These companies consolidate or grow their leadership position by continuously innovating and creating new products and solutions that serve ever-evolving customer needs.
“Eurosets, with the right product and the right presence in the field, is well positioned to scale up rapidly by riding on the ECMO growth wave.”
Srinath Venkatasubramanian, Industry Analyst, Transformational Health
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make of break today’s market participants. For more than 60 years, Frost & Sullivan have been developing growth strategies, coaching organizations of all types and sizes across 6 continents.
